Found 5 matching trials
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis PHASE2 This is a multi-part, randomized, double-blind, placebo-controlled Phase 2 ...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis N/A The purpose of this expanded access program (EAP) protocol is to provide in...
Show More Location
Orso Health/Modena Asthma Allergy
Learn More & Join Trial
CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors PHASE1 The goal of this clinical research study is to learn how CGT9486 (fka PLX94...
Show More Location
Sylvester Comprehensive Cancer Center/ UMHC
Learn More & Join Trial
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis PHASE2 This is an open-label, two-part Phase 2 study investigating CGT9486 for the...
Show More Location
University of Alabama at Birmingham (UAB) Hospital
Learn More & Join Trial
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors PHASE3 This is a Phase 3, open-label, international, multicenter study of CGT9486 ...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial